Eggs that don’t get released during ovulation are reabsorbed by the body through a process called follicular atresia, a form of programmed cell death. This isn’t a waste or a failure; it’s actually the default outcome for the vast majority of your eggs. About 99.9% of ovarian follicles will undergo atresia over the course of your lifetime, and only a tiny fraction will ever be selected for ovulation. But the story gets more interesting when anovulation isn’t just the normal winnowing process and instead reflects something going wrong with the hormonal signals that drive egg selection and release.
The Default Fate of Almost Every Egg
You’re born with a fixed pool of eggs, somewhere in the range of one to two million. By puberty, that number has already dropped to a few hundred thousand, and over your reproductive years, only about 400 to 500 will ever mature and be released during ovulation. The rest quietly die off through atresia. This process involves the support cells surrounding the egg, called granulosa cells, undergoing apoptosis, which is the body’s orderly way of dismantling cells that are no longer needed. Research has confirmed that atresia in normal follicles follows this programmed cell death pathway, with characteristic DNA fragmentation patterns visible in granulosa cells of atretic follicles.1PubMed. Biochemical identification of apoptosis (programmed cell death) in granulosa cells: evidence for a potential mechanism underlying follicular atresia
Atresia isn’t random. It’s a selection mechanism. Each menstrual cycle, a batch of follicles begins developing in response to hormonal signals, but only one (sometimes two) emerges as the “dominant” follicle that gets enough hormonal support to reach full maturity and ovulate. The rest of that batch, and the thousands of follicles that never even got recruited into active growth, undergo atresia. The process serves as quality control, ensuring that the follicle most likely to produce a viable egg is the one that gets released.2PubMed Central. Mechanisms of follicular atresia: focus on apoptosis, autophagy, and ferroptosis
Once a follicle undergoes atresia, it doesn’t just disappear in one step. The egg cell within it degenerates, the granulosa cells break down, and the remnant is gradually absorbed by surrounding ovarian tissue. There’s no scarring, no buildup of debris. Your ovary handles this cleanup thousands of times over your life without you noticing a thing.
When Anovulation Is a Problem, Not a Process
Normal atresia is healthy. But anovulation, where your body fails to release an egg during a cycle when it should, is a different situation. In anovulatory cycles, the hormonal cascade that’s supposed to push one follicle to dominance and trigger its release stalls out. Follicles may start growing but never get the signal to finish the job. What happens to those follicles depends on what’s causing the anovulation.
In polycystic ovary syndrome, one of the most common causes of chronic anovulation, follicles get stuck. They begin developing but fail to grow past the mid-antral stage, the point where a follicle is partway to maturity. Instead of one dominant follicle emerging, you end up with an unusually high number of small follicles clustered around the ovaries. These stalled follicles show signs of granulosa cell degeneration and overgrowth of the surrounding theca cells.3PubMed Central. Disordered follicle development The characteristic “string of pearls” appearance on an ultrasound comes from this accumulation of arrested follicles. They don’t ovulate, but they also don’t fully undergo normal atresia on the expected timeline. Eventually they do break down and get reabsorbed, but the cycle of stalling and incomplete resolution can persist for months or years.
Androgen excess appears to play a key role in this disordered follicle development. Research suggests that receptors for androgens on theca cells may mediate many of the negative effects that lead to anovulatory infertility in PCOS.4PubMed Central. Physiological and Pathological Androgen Actions in the Ovary The follicles are getting mixed signals: enough stimulation to start growing, but the wrong hormonal environment to finish.
Stress, Thyroid Problems, and Other Hormonal Disruptions
Not all anovulation involves follicles getting stuck partway through development. In some cases, the brain simply stops sending the signal to start the process in the first place. Chronic stress can suppress the hormonal pulses from the hypothalamus that kick off each cycle’s follicle recruitment. The stress response interferes with the signaling system that controls the release of reproductive hormones, and ovulation shuts down as a result.5PubMed Central. Chronic Stress and Ovulatory Dysfunction: Implications in Times of COVID-19 In this scenario, follicles still undergo their normal background rate of atresia, but fewer are being actively recruited into the growth pipeline. Your egg supply continues to decline at its usual pace through natural attrition, even though you’re not ovulating.
Thyroid dysfunction creates a similar problem through a different route. Hypothyroidism can raise prolactin levels, which in turn suppresses the hormones needed for ovulation. The result is amenorrhea, the absence of menstrual periods, because the feedback loop between estrogen and the brain’s hormonal signals gets disrupted.6PubMed Central. Correlation of Prolactin and Thyroid Hormone Concentration with Menstrual Patterns in Infertile Women The eggs themselves aren’t damaged by this process. They’re simply not being called up for duty. Fix the thyroid problem, and ovulation often resumes.
This is an important distinction for anyone worried about “losing” eggs during periods of anovulation. Whether you’re ovulating or not, your ovarian reserve declines over time through atresia. Not ovulating doesn’t “save” your eggs for later. The eggs that would have undergone atresia anyway still do. You’re simply not releasing the one that would have been selected as dominant.
What Hormonal Contraception Does to Your Follicles
Birth control pills, patches, and rings suppress ovulation deliberately. This is their primary job. But they don’t freeze your ovaries in place. Follicles continue to grow to the early antral stage even while you’re on hormonal contraception. The contraceptive mainly blocks the ovulatory surge of hormones that would push a follicle to final maturity and release, so follicles start developing and then undergo atresia at a slightly earlier stage than they otherwise would.7Endocrine Reviews. Initial and Cyclic Recruitment of Ovarian Follicles
Long-term use of combined hormonal contraceptives can temporarily suppress the visible count of small antral follicles on ultrasound. One study found that this suppression was more likely with combined hormonal contraceptive use, but it was reversible: after stopping contraception, follicle counts began improving within about a month, with recovery plateauing around six to seven months.8PubMed Central. Long-term hormonal contraceptive use is associated with a reversible suppression of antral follicle count and a break from hormonal contraception may improve oocyte yield The underlying pool of eggs isn’t depleted faster or slower by the pill. What changes is the snapshot you’d see on an ultrasound at any given moment.
This has practical implications if you’re planning fertility treatments. If you’ve been on hormonal contraception and are about to undergo egg retrieval, your doctor may suggest stopping contraception a few months beforehand so that your antral follicle count better reflects your actual ovarian reserve.
The Uterine Lining Risk That Gets Overlooked
The eggs themselves are only part of the story. When you don’t ovulate, your body also misses a critical step in its monthly hormonal cycle: the production of progesterone. After ovulation, the leftover follicle transforms into a structure called the corpus luteum, which produces progesterone. Progesterone counterbalances estrogen’s effect on the uterine lining, stabilizing it and eventually triggering the shedding that becomes your period. Without ovulation, there’s no corpus luteum, no progesterone spike, and estrogen continues to build up the uterine lining without opposition.
This “unopposed estrogen” situation is more than a hormonal imbalance. Chronic anovulation creates an environment where the endometrial lining keeps thickening, and over time this raises the risk of endometrial hyperplasia, an overgrowth that can become a precursor to uterine cancer. The risk is amplified by factors that commonly accompany anovulation, including obesity and insulin resistance.9Trends in Immunotherapy. Immunoinflammatory and Metabolic Drivers of Endometrial Hyperplasia: From Unopposed Estrogen to Precision Medicine
Clinical evidence bears this out in dramatic fashion. In one documented case, a premenopausal woman with chronic anovulation showed a clear stepwise progression of endometrial changes over time: from normal proliferation to cystic hyperplasia, then to atypical hyperplasia, and eventually to invasive cancer, all attributed to prolonged exposure to estrogen without the balancing effect of progesterone.10PubMed. Endometrial carcinoma following chronic anovulation in a premenopausal woman with systemic lupus erythematosus This is why doctors take chronic anovulation seriously even in women who aren’t trying to conceive. Periodic progesterone treatment or hormonal contraception is often prescribed specifically to protect the uterine lining.
Luteinized Unruptured Follicle Syndrome
There’s a peculiar middle ground between normal ovulation and full anovulation that many people haven’t heard of. In luteinized unruptured follicle syndrome, or LUF, the follicle goes through all the hormonal motions of ovulation. It matures, it responds to the hormonal surge, it even starts producing progesterone as if ovulation happened. But the egg never actually escapes the follicle. The follicle “luteinizes” (transforms as it should after ovulation) without rupturing.
From the outside, a LUF cycle can look completely normal. Your basal body temperature rises, your progesterone levels increase, and your period arrives on schedule. The only way to definitively catch it is through ultrasound monitoring, where the follicle is seen growing but never collapsing after the expected ovulation date. The trapped egg simply degenerates inside the luteinized follicle, which is eventually reabsorbed.
LUF can be an occasional, harmless event, but when it happens repeatedly it becomes a cause of unexplained infertility. Research on women undergoing frozen embryo transfer in natural cycles found that those with LUF had lower clinical pregnancy rates compared to women who ovulated normally, with the gap being most pronounced when certain hormone levels were on the lower side.11PubMed Central. Impact of Luteinized Unruptured Follicles on Clinical Outcomes of Natural Cycles for Frozen/Thawed Blastocyst Transfer The condition is thought to be more common with the use of certain anti-inflammatory medications, which may interfere with the enzymes needed for the follicle wall to break open.
Egg Quality and the Ticking Clock
A common question linked to anovulation is whether eggs that sit around longer lose quality. The answer is complicated, because egg quality decline is driven primarily by age, not by whether individual eggs were “used” or not. Your eggs have been sitting in a suspended state since before you were born. Every egg in your ovary right now has been paused in an early stage of cell division for decades, and the longer that pause lasts, the more opportunity there is for cellular damage to accumulate.
The main culprits in age-related egg quality decline are oxidative stress and mitochondrial dysfunction. Mitochondria, the energy-producing structures inside cells, deteriorate over time, and this deterioration is especially problematic in eggs because they depend heavily on mitochondrial function to fuel the cell division that happens after fertilization. Research has identified oxidative damage and mitochondrial dysfunction in oocytes as key factors in the poor egg quality seen in women of advanced maternal age, with this damage occurring even at the earliest dormant follicle stage.12PubMed Central. The quality of human eggs and its pre‐IVF incubation
This means that anovulation neither protects nor further damages your eggs in any meaningful way. The decline is happening at the cellular level regardless of whether those eggs are being recruited into active cycles. Women who ovulate regularly and women who don’t ovulate for years due to contraception or medical conditions end up with roughly the same age-related decline in egg quality when they eventually try to conceive.
Primary Ovarian Insufficiency
Sometimes anovulation signals that the egg supply itself is running dangerously low. Primary ovarian insufficiency, previously called premature ovarian failure, is a condition where the ovaries lose normal function before age 40. It affects roughly one in 100 women under 40 and about one in 1,000 under 30. The hallmarks are absent periods, low estrogen, and elevated levels of the hormones that the brain produces when it’s trying unsuccessfully to stimulate the ovaries.13PubMed Central. Premature Ovarian Insufficiency: Past, Present, and Future
In primary ovarian insufficiency, the follicle pool has been depleted ahead of schedule. The eggs aren’t failing to ovulate because of a hormonal signaling problem that could be corrected. They’re simply gone, or so few remain that the ovary can’t sustain normal cycling. Some women with the condition do experience intermittent ovarian function, with occasional spontaneous ovulation and even rare pregnancies, but the trajectory is toward early menopause. Causes include genetic conditions, autoimmune disorders, chemotherapy, and radiation, though in many cases no specific cause is ever identified.
Perimenopause and the Final Decline
Even in women with perfectly normal reproductive histories, anovulation becomes increasingly common in the years leading up to menopause. During perimenopause, which can begin in the early to mid-40s, the remaining follicle pool shrinks to the point where the hormonal feedback loops that drive regular ovulation start to falter. Estrogen and progesterone production drops, and the brain’s signaling networks that regulate reproductive cycling undergo significant remodeling.14PubMed Central. Reproductive aging in biological females: mechanisms and immediate consequences
During this transition, cycles become unpredictable. Some months you may ovulate normally, others you won’t. The remaining follicles still undergo atresia at the usual rate, but with fewer follicles in the starting pool, the odds of successfully selecting a dominant follicle each month get worse. The anovulatory cycles of perimenopause carry the same unopposed-estrogen risk to the uterine lining described earlier, which is one reason why irregular heavy bleeding is so common during this phase.
Environmental Exposures and Your Follicle Reserve
There’s growing concern about whether environmental chemicals can accelerate the rate at which follicles are lost to atresia. Animal research has shown that exposure to known endocrine-disrupting chemicals during early development can alter the distribution of follicles in the ovary, with a trend toward fewer early-stage follicles in adulthood. Researchers have described this as potentially reflecting an accelerated loss of follicle reserves, driven by the combined influence of disrupted hormone receptor activity and altered steroid production in the ovary.15PubMed. Perinatal exposure to known endocrine disrupters alters ovarian development and systemic steroid hormone profile in rats
Translating animal findings to humans requires caution. The doses, timing, and specific chemicals studied in rodent models don’t map neatly onto human exposures. But the principle is biologically plausible: if chemicals can interfere with the hormonal environment that governs follicle survival and atresia, they could theoretically shift the balance toward faster depletion. This is an active area of research with no firm conclusions yet for human populations, but it adds context to why reproductive health advocates push for reducing unnecessary chemical exposures.
How Doctors Assess What’s Left
If you’re experiencing anovulation and want to know what’s happening with your egg supply, the most commonly used tool is a blood test for anti-Müllerian hormone, or AMH. AMH is produced by the small growing follicles in your ovaries, and its level in the blood reflects the size of your remaining follicle pool. Because it stays relatively stable throughout the menstrual cycle, it’s considered the go-to marker for assessing ovarian reserve and predicting how the ovaries will respond to fertility treatments.16PubMed Central. The effect of medication on serum anti-müllerian hormone (AMH) levels in women of reproductive age: a meta-analysis
AMH testing has limits, though. It tells you about quantity, not quality. A woman with a good AMH level for her age still has eggs that are the same biological age as she is, with the corresponding decline in quality. And as noted earlier, hormonal contraception can temporarily suppress AMH readings, so the timing of the test matters. Antral follicle count on transvaginal ultrasound provides a complementary picture, showing the number of small follicles visible at the start of a cycle. Together, these two measurements give the clearest available snapshot of where things stand, though neither one can tell you exactly how many eggs remain or predict exactly when menopause will arrive.
For women experiencing anovulation who aren’t trying to conceive, the practical takeaway is less about egg counting and more about managing the downstream effects: protecting the uterine lining from unopposed estrogen, monitoring for metabolic issues that often accompany chronic anovulation, and addressing the underlying cause when one can be identified. The eggs that don’t ovulate were always going to be reabsorbed. The real question is usually what the anovulation itself signals about your hormonal health.